Founded in 1897, Wenzhou Central Hospital (The Second Hospital Affiliated to Shanghai University) is one of the three famous century-old hospitals in Zhejiang Province. As a general Grade-A tertiary hospital, it has grown from Dihgley Hospital, Blyth Hospital, Wenzhou Second People's Hospital, to Wenzhou Central Hospital, playing an important role in the medical industry of Wenzhou, and continuing the depth of the history of Wenzhou as well. In recent years, the hospital has successively become Wenzhou Institute of Pharmaceutical Sciences, Wenzhou Medical University Dihgley Clinical College, the first batch of national standardized training bases for resident doctors, the first batch of national pilot hospitals for non-invasive DNA prenatal screening, National Advanced Stroke Center, TCM Work Demonstration Unit of National Comprehensive Hospital, Zhejiang Provincial Hospital of Cancer Pain Standardized Treatment, National Chest Pain Center, National Cardiac Rehabilitation Center, Wenzhou Branch of Tumor Hospital of University of Chinese Academy of Sciences, Geriatrics and Public Health Research Institute of Shanghai University, and Wenzhou Geriatrics Medical Center. Furthermore, Wenzhou Central Hospital has developed the world's first genetic database for hereditary bone diseases.
The hospital has three branches, Bailifang, Shuangyu and Nanbaixiang, between which differentiated development strategy is implemented. Bailifang Branch focuses on geriatric medicine, Shuangyu Branch (namely Wenzhou Tumor Hospital) focuses on diagnosis and treatment of tumors, and Nanbaixiang Branch (namely Wenzhou Sixth People's Hospital) focuses on prevention and treatment of infectious diseases. It has two major academician team workstations of neurosurgery academician Zhou Liangfu and gastroenterology academician Li Zhaoshen, two provincial and municipal key discipline departments such as neurology and tumor radiotherapy, two provincial special disease centers such as neurosurgery and haematology, and three municipal special disease centers such as neurosurgery, tumor (centering on radiotherapy), infectious diseases, etc. It also has 6 municipal key disciplinary systems of brain, tumor diagnosis and treatment, prenatal diagnosis, cerebrovascular disease, infectious disease, and chest pain, etc., 14 municipal key medical disciplines of urinary surgery, gastroenterology, radiotherapy, surgical oncology, neurology, emergency medicine, cardiovascular medicine, neurosurgery, hematology, infectious diseases, liver and gallbladder surgery, clinical diagnostic test, gynecological oncology, and ultrasonic medicine, etc., and 12 municipal diagnosis and treatment quality control institutions, and 24 medical technology guidance centers.
Wenzhou Oncology Hospital was built in 1985 and officially put into use in 1987. It is one of the only two specialized oncology hospitals in Zhejiang Province, and is the earliest hospital that conducts integrated treatment of tumors by adopting radiotherapy, chemotherapy and surgery in our city. Wenzhou Tumor Prevention and Control Office, Wenzhou Anti-cancer Association, Wenzhou Tumor Diagnosis and Treatment Quality Control Center, Wenzhou Tumor Radiotherapy Center, and Wenzhou Gynecological Oncology Technical Guidance Center are all located in the hospital.
During the SARS pandemic in 2003, in accordance with the requirements of the municipal government, Wenzhou Oncology Hospital completed asset merger and restructure with Wenzhou Second People's Hospital, aiming at relying on its strong comprehensive technical strength to promote the rapid development of oncology medical level. After great efforts in recent years, the medical level of the hospital oncology has been significantly improved, and rapid growth has been made in the diagnosis, treatment, scientific research and prevention of tumors. In 2007, "Wenzhou Oncology Medical Center" was established, and it cooperated with Affiliated Oncology Hospital of Fudan University to set up Wenzhou Clinical Base of Affiliated Oncology Hospital of Fudan University, striving to foster a brand of multidisciplinary integrated treatment combining oncology medical treatment with prevention and rehabilitation.
In 2008, the hospital’s oncology discipline group of was approved as the third round of 311 Construction Project of Wenzhou City, and the Oncology Hospital maintained a good momentum of rapid growth. In 2009, the hospital expedited the implementation of single-disease multi-disciplinary integrated and standardized treatment of tumors, having achieved good results. At the end of 2010, the reconstruction and expansion project of Wenzhou Oncology Hospital (Oncology Hospital Area of Wenzhou Second People's Hospital) was officially put into operation. The hospital has the total constructed land area of about 70 mu, with a total overall floorage of 44,127 square meters.
Currently, the Oncology Hospital has 181 permanent staff, including 153 professional technicians, 28 administration and logistics staff, and 108 retirees. There are 8 directors and 32 deputy directors. With 250 approved beds, the hospital has complete departments and advanced equipment, including a large number of cutting-edge oncology equipment like mammography machine, linear accelerator, electronic accelerator, cobalt 60 therapy machine, deep X-ray therapy machine, multi-functional breach-loading therapy machine, and full-body stereotactic radiotherapy system. Many of the advanced medical projects are only owned by the Oncology Hospital and other hospitals don’t have them in the whole city, such as gynecological tumor endoluminal bleach-loading therapy instrument, breast disease treatment center, Many of these medical items are advanced and unique in the city, such as gynecological tumor endoluminal post-treatment instrument, mammary gland disease treatment center, cervix uteri specialist outpatient clinic, full-set tumor marker test, and chemotherapy ward set up independently.
This further enhances the overall diagnosis and treatment level of the Oncology Hospital, increases the consultation rate of tumor patients and builds more trust among them. 35.1% of the hospital area is covered by green plants, with a beautiful and comfortable environment. Integrating the unique natural scenery of Huanglongshan Park, it will become a modern garden-style hospital that specializes in prevention, medical treatment, scientific research and teaching.
Wenzhou Sixth People's Hospital, one of the three core member units of Wenzhou Central Hospital Group, is a specialist hospital that mainly conducts diagnosis and treatment of infectious diseases. It is a standardized training base for resident doctors, with professional teams engaging in clinical medicine, teaching and scientific research. It sets up Hepatology Department, Tuberculosis Department, General Internal Medicine Department, ICU and other departments. It has a municipal key discipline group - Infection Department, which has opened specialized clinics for 6 kinds of infectious diseases, such as infections, liver diseases, intestinal diseases, fevers, tuberculosis, and special need services, and multidisciplinary joint outpatient clinic for fatty livers. There are 135 beds in the ward, 16 beds in an ICU with standard configuration, 4 units of negative pressure wards. Annually, more than 2100 patients are discharged from the hospital, and more than 60,000 outpatients receive medical treatment. It is equipped with relevant auxiliary departments such as Clinical Lab, Clinical Laboratory, Radiology Department and Ultrasonography Lab.
At present, the hospital offers technological tests in organ function support, artificial liver support, vascular interventional therapy, hepatitis virus genetic typing and hepatitis B virus P-section nucleoside analogue drug resistance, as well as fast tubercle bacillus test and related drug sensitivity test such as solid and liquid culture of mycobacterium tuberculosis, antimicrobial susceptibility test, Gene-Xpert, and Hains probe, which has laid a strong foundation for the quick diagnosis and treatment of clinical diseases.
Now, there are 127 staff and 116 professional medical personnel. Professionally trained specialists and nurses have made up the medical teams, which are featured with down-to-earth style, distinct echelon and reasonable allocation. With strong technical force, sub-specialty department is well-equipped clinical department that integrates medical treatment, teaching and scientific research. The hospital has 8 medical staff with senior professional titles, 3 chief physicians, 20 professionals with intermediate professional titles, one Wenzhou 311 key discipline pacesetter, one Wenzhou key discipline group pacesetter, one Wenzhou "Ouyue Famous Doctor", and three Wenzhou New Century 551 talents. All the doctors hold bachelor degrees or above, including 8 master degree holders, and one doctoral candidate.
As a designated hospital of Health and Family Planning Commission at the provincial and municipal levels, our hospital has made rapid progress in tuberculosis diagnosis and treatment technology in recent years. Tuberculosis patients can enjoy the national exemption policy, and some eligible patients are even entitled to the support from the Global Fund. With the use of ICU for infectious diseases, the treatment level and success rate have been further improved for patients with tuberculosis combined with haemoptysis, severe tuberculosis patients, and those with organ organ dysfunction. Laboratory testing technology has taken the lead provincewide and nationwide. In addition to carrying out solid and liquid culture of mycobacterium tuberculosis, and drug sensitivity test, the laboratory also offer fast tubercle bacillus test and related drug sensitivity test such as Gene-Xpert, Hains probe etc. , which can quickly identify non-tuberculous mycobacterium. It takes only 2-3 hours to get the results of antimicrobial susceptibility test that originally required more than two month to cultivate. This provides a strong foundation for rapid clinical diagnosis and treatment of diseases.
In the past five years, three major national projects of the 12th Five-Year Plan that have been participated in include clinical research on hepatitis B cirrhosis treatment by using Chinese medicine combined with entecavir (2014ZX10005001), research on a new chemotherapeutic treatment plan for relapsed tuberculosis (2013ZX10003009), optimal treatment plan for multi-drug-resistant tuberculosis (2013ZX10003008), and the global multi-drug-resistant tuberculosis fund project. Other projects undertaken are one departmental project, 14 municipal projects, and 5 bureau projects. More than one million yuan scientific research expenditure subsidy has been obtained. In the past 5 years, published writings include 3 SCI papers, over 20 articles in Chinese medical journals, and more than 100 related papers.
